DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
von Minckwitz G, Hahnen E, Fasching PA.
Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): results from Gepar-Sixto.
J Clin Oncol 2014;
32: 5s (Suppl. Abstr. 1005)
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.